<DOC>
<DOCNO>
EP-0005911
</DOCNO>
<TEXT>
<DATE>
19791212
</DATE>
<IPC-CLASSIFICATIONS>
C07D-251/46 A61P-25/00 <main>C07D-251/46</main> A61P-25/04 C07D-251/38 C07D-403/02 C07D-251/00 A61K-31/53 
</IPC-CLASSIFICATIONS>
<TITLE>
analgesic 6-acylaminotetrahydro-1,3,5-triazine-2,4-dione derivatives, pharmaceutical compositions thereof, and process for their manufacture.
</TITLE>
<APPLICANT>
ici ltdgb<sep>imperial chemical industries limited<sep>imperial chemical industries plcimperial chemical house, millbanklondon sw1p 3jfgb<sep>imperial chemical industries plc  <sep>
</APPLICANT>
<INVENTOR>
brown edward douglas<sep>brown, edward douglas<sep>brown, edward douglas27 ashworth parkknutsford cheshiregb<sep>brown, edward douglas<sep>brown, edward douglas27 ashworth parkknutsford cheshiregb<sep>
</INVENTOR>
<ABSTRACT>
compounds of the formula:    in which r¹ is an optionally substituted phenyl, phenyl-(1-4c)alkyl-  naphtyl, monocyclic or bicyclic heteroaromatic  or (monocyclic or bicyclic heteroaromatic)-(1-4c) alkyl radical,  r² is a (3-8c) alkyl or a (1-4c)-alkyl bearing one or two  (1-4c) alkoxy or a 1,3-dioxalanyl, tetrahydrofuryl or tetrahydropyranyl  substituent or is a (3-8c)cycloalkyl, [(3-8c)cycloalkyl]  - (1-4c)alkyl or 3-6c)alkenyl radical, or an  optionally substituted phenyl or phenyl- (1-4c)-alkyl radical,  and r³ is a (1-4c)alkyl radical, preferably a methyl radical;  together with pharmaceutically acceptable salts thereof.  also  provided are processes for the manufacture of, and pharmaceutical  compositions of the derivatives and salts thereof.   some of the derivatives possess anti-inflammatory properties  and/or are inhibitors of the enzyme prostaglandin  synthetase in addition to possessing analgesic properties.  
</ABSTRACT>
</TEXT>
</DOC>
